Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.96 USD
+0.06 (6.69%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.94 -0.02 (-2.10%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | -6.25% |
ABR | 1.86 |
Earnings ESP
|
130.00% |
---|---|
Current Year | -0.47 |
Next Year | -0.09 |
EPS (TTM) | -1.12 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 26.55M | 38.85M | 44.47M | 118.57M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 40.00M | 60.00M | 100.80M | 202.00M |
Low Estimate | 13.10M | 17.70M | 1.00M | 53.70M |
Year ago Sales | 9.40M | 2.04M | 176.23M | 44.47M |
Year over Year Growth Est. | 182.45% | 1,804.41% | -74.77% | 166.64% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.02 | -0.47 | -0.09 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | 0.02 | 0.08 | -0.23 | -0.15 |
High Estimate | 0.02 | 0.08 | -0.23 | 0.18 |
Low Estimate | -0.14 | -0.12 | -0.70 | -0.27 |
Year ago EPS | -0.34 | -0.34 | -0.59 | -0.47 |
Year over Year Growth Est. | 79.41% | 94.12% | 20.34% | 80.85% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.02 | -0.47 | -0.09 |
7 Days Ago | -0.07 | -0.02 | -0.47 | -0.09 |
30 Days Ago | -0.11 | -0.07 | -0.51 | -0.08 |
60 Days Ago | -0.11 | -0.04 | -0.55 | -0.15 |
90 Days Ago | -0.11 | -0.04 | -0.55 | -0.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | 0.08 | -0.23 | -0.15 |
Zacks Consensus Estimate | -0.07 | -0.02 | -0.47 | -0.09 |
Earnings ESP | 130.00% | 500.00% | 51.06% | -66.67% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.27 | -0.34 | -0.34 | NA |
Estimate | -0.16 | -0.22 | -0.25 | -0.33 | NA |
Difference | -0.01 | -0.05 | -0.09 | -0.01 | -0.04 |
Surprise | -6.25% | -22.73% | -36.00% | -3.03% | -17.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more